Inflammatory Bowel Disease Drugs Market
The report also provides a detailed analysis of the current Inflammatory Bowel Disease Drugs marketed drugs and late-stage pipeline drugs. The increasing prevalence of inflammatory gastrointestinal disorders owing to several associated factors, such as genetic predisposition, environmental triggers, immune system disturbances, etc., is primarily driving the market.